EVOQ THERAPEUTICS, INC.
Biotech · Private
Synthetic high-density lipoprotein NanoDiscs for targeted peptide antigen delivery to lymph nodes
- Grants
- $4.8M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel immunotherapy against MOG antibody disease | $287,733 | |
| Federal grant | Department of Health and Human Services · Phase II · New approach for immune modulation against T1D | $761,809 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel immunotherapy against MOG antibody disease | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · New approach for immune modulation against T1D | $756,491 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel immunotherapy against MOG antibody disease | $988,943 | |
| Federal grant | Department of Health and Human Services · Phase II · NanoDiscs for Immune Modulation in Celiac Disease | $1,050,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1696 | ONECYTE BIOTECHNOLOGIES, INC. | — | — |
| 1697 | Igenica | — | — |
| 1698 | ZabBio, Inc. | — | — |
| 1699 | EVOQ THERAPEUTICS, INC. | — | — |
| 1700 | OMass Therapeutics | — | — |
| 1701 | Purespring Therapeutics | — | — |
| 1702 | TEGA THERAPEUTICS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.